Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.

In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Researchers used biochemical and RNA sequencing analyses to explore how disease-associated ... role of RNA-binding domain 3, a key portion of ADAR1, in maintaining the protein's activity and ...

New research pioneered by The University of Western Australia is shedding light on the intricate dance between proteins, DNA ...

The structure of the PP7 bacteriophage coat protein revealed a mode of RNA binding that is distinct from that of the well-characterized MS2 coat protein, suggesting new orthogonal systems for RNA ...

Researchers suggest discovery of genetic link between ASD and DM1 opens up potential new therapeutic avenues for ASD.

Another reason for choosing a particular modality is that it is a team’s specialty. Strategic choices can be less about determining which modality best fits a potential target than about choosing a ...

The realization that most human genes generate multiple mRNAs encoding divergent protein isoforms via alternative splicing ... to physiological change including in development and disease. We are ...

Biologists have discovered that disruptions in transfer RNA function can lead to the development of cleft lip and cleft palate.

The world of drug discovery and chemical probes is still protein-centric and developing highly selective small molecules targeting RNA is often considered to be an insurmountable challenge.